Fonarow Gregg C
Ahmanson-UCLA Cardiomyopathy Center, UCLA Preventive Cardiology Program, UCLA Division of Cardiology, Los Angeles, California, USA.
Rev Cardiovasc Med. 2007;8 Suppl 4:S25-36.
Despite overwhelming evidence supporting the benefits of cardiovascular protective therapies and risk reduction in patients with or at risk for coronary heart disease, these strategies remain underutilized in clinical practice. Preventive cardiology guidelines from the American Heart Association, the American College of Cardiology, and others focus on primary and secondary prevention with the use of medications, risk factor control measures, and lifestyle modification. Still, a "treatment gap" remains between the guidelines and their actualization. A systematic approach including both inpatient and outpatient measures is necessary. This article discusses the current guidelines and addresses ways to increase implementation of evidence-based, guideline-recommended treatment by healthcare providers caring for at-risk patients.
尽管有大量证据支持心血管保护疗法以及降低冠心病患者或有冠心病风险患者的风险的益处，但这些策略在临床实践中仍未得到充分利用。美国心脏协会、美国心脏病学会等机构发布的预防心脏病学指南侧重于通过使用药物、风险因素控制措施和生活方式改变进行一级和二级预防。然而，指南与其实际应用之间仍存在“治疗差距”。需要一种包括住院和门诊措施的系统方法。本文讨论了当前的指南，并探讨了由照顾高危患者的医疗服务提供者增加实施基于证据的、指南推荐治疗的方法。
Zotero 插件